Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

1.40
Delayed Data
As of Apr 29
 -0.11 / -7.28%
Today’s Change
1.28
Today|||52-Week Range
12.55
-56.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$142.4M

Company Description

Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. It engages in the provision of developing cancer vaccines designed to treat a solid tumor cancers. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

Contact Information

Northwest Biotherapeutics, Inc.
4800 Montgomery Lane
Bethesda Maryland 20814
P:(240) 497-9024
Investor Relations:
(202) 841-7909

Employees

Shareholders

Other institutional9.49%
Individual stakeholders48.26%
Mutual fund holders28.87%

Top Executives

Linda F. PowersChairman, President, CEO, CFO & CAO
Alton L. BoyntonChief Scientific Officer & Secretary
Marnix L. BoschChief Technology Officer
Anthony E. MaidaSenior Vice President-Clinical Research
Leslie J. GoldmanSVP-Business Development & IR Contact